Objectives: Localized provoked vulvodynia (LPV) afflicts approximately 8% of women in the United States and represents a huge financial, physical, and psychological burden. Women with LPV experience intense pain localized to the vulvar vestibule (area immediately surrounding vaginal opening). We have identified mechanisms involved in the development of LPV whereby vulvar fibroblasts respond to proinflammatory stimuli to perpetuate an inflammatory response that causes pain. However, these mechanisms are not fully elucidated. Therefore, we explored the role of toll-like receptors (TLRs), a class of innate immune receptors that rapidly respond to microbial assaults.
V ulvodynia is a poorly understood, common, chronic, and debilitating condition that afflicts women worldwide. [1] [2] [3] Women with localized provoked vulvodynia (LPV) experience intense pain concentrated within the vulvar vestibule (area immediately surrounding vaginal opening) in response to light touching, clinically known as allodynia. 1 Despite experiencing severe and longlasting pain, LPV patients exhibit no clinically visible signs of disease (no scarring or lesions), making it challenging to identify the underlying cause of disease. 1, 3 Therefore, currently available therapeutic approaches only manage the outward symptoms of LPV and do not address the underlying origins of pain.
We discovered that fibroblasts isolated from sites of allodyniatype pain in LPV patients are inherently highly sensitive to proinflammatory stimuli (e.g., live yeast, zymosan), producing high levels of proinflammatory mediators (e.g., interleukin 6 [IL-6] and prostaglandin E 2 ) linked to pain. [4] [5] [6] Furthermore, the levels of fibroblast proinflammatory mediator production accurately predict pain thresholds to mechanical stimuli; the highest amounts of mediators are produced by fibroblasts isolated from the most intense pain threshold-confirmed sites. 5 Although the magnitude of the inflammatory response is greatest in LPV patients, the vestibule seems to have an inherent proclivity to inflammation, even in healthy women. 4, 5 We have subsequently identified receptors (e.g., Bradykinin receptors 1 and 2 and Dectin-1) that contribute to this maladaptive inflammation response. 4, 7 However, inactivating one or more of these receptors does not completely disrupt proinflammatory mediator production, pointing to the existence of other coexisting receptors/mechanisms. 4, 7 Toll-like receptors, an important class of pattern recognition receptors (PRRs), are quickly responsive to microbes and play a central role in initiating immune responses to a variety of bacterial, viral, and fungal stimuli. [8] [9] [10] [11] Ten TLRs are expressed in humans, each of which recognizes pathogen-associated molecular patterns (PAMPs) associated with specific harmful stimuli. 8, 9, [12] [13] [14] [15] Tolllike receptor signaling results in the production of proinflammatory, pain-associated mediators (e.g., IL-6 and prostaglandin E 2 ), among others that initiate both innate and adaptive immunity and recruit immune cells to sites of infection. 8, 9, [12] [13] [14] [15] However, excessive/inappropriate proinflammatory mediator production can lead to chronic, painful disease states, [9] [10] [11] including rheumatoid arthritis, gout, and systemic lupus erythematosus. 10 Because TLRs play a central role in the immune response and may promote chronic pain conditions, we became interested in TLR signaling in the context of LPV. [8] [9] [10] [11] Before our work, it was not known whether vulvar fibroblasts even express TLRs. Here, we present the first evidence that human vulvar fibroblasts do indeed express TLRs, which play a role in vulvar inflammation and pain.
MATERIALS AND METHODS

Patient/Sample Selection and Fibroblast Strains
Localized provoked vulvodynia-afflicted cases (fulfilling Friedrich criteria 16 ) and age/race-matched pain-free controls were recruited by the Division of General Obstetrics and Gynecology at the University of Rochester between December 2012 and February 2014. Selection and sampling procedures were previously published. 5, 6 All subjects provided written informed consent, and the research was approved by the University of Rochester Institutional Review Board (RSRB # 42136). Primary fibroblast "strains" from individual patients were cultured as previously described.
Toll-Like Receptor Messenger RNA Expression
Toll-like receptor 1-9 messenger RNA (mRNA) expression was evaluated in three LPV case and two paired control fibroblast strains using reverse transcriptase quantitative PCR. 4, 7 Toll-like receptors expression was determined using previously published methods. [17] [18] [19] [20] Messenger RNA expression of TLR-3, TLR-7, and TLR-9 was also evaluated in whole tissue biopsies of three LPV cases, collected as previously described. 5, 21 Toll-like receptors messenger RNA levels were compared by anatomic location, within subjects, and by case/control status between subjects.
Toll-Like Receptor Activity
Paired strains from a prototypical case 5 were challenged with stimuli that activate the full range of human TLRs using the Human TLR 1-9 Agonist Kit (InvivoGen USA, San Diego, CA). Interleukin 6 was analyzed by ELISA 4, 7 ; IL-6 is a measure of TLR proinflammatory activity. 8, 9, [12] [13] [14] [15] 
Toll-Like Receptor 7 Protein Expression
Protein levels of TLR-7 were measured by Western blotting in three paired case strains 4,7 using a primary antibody specific for TLR-7 (GeneTex Inc, Irvine, CA). Toll-like receptor 7 expression levels were quantified by densitometric analysis and normalized to a control protein (β-tubulin; Cell Signaling Technology, Danvers, MA).
Response of Vulvar Fibroblasts to Live HIV Exposure
Human fibroblasts were treated with live HIV virus (50 or 200 ng of p24), and after 3 and 7 days, cells and supernatants were tested for p24 protein by ELISA to assess HIV-1 particle release. To determine intracellular levels of p24 expression, cells were harvested and analyzed by flow cytometry. Toll-like receptor 7 mRNA and IL-6 levels were quantified for cells exposed to live HIV. FIGURE 1. Localized provoked vulvodynia patient fibroblasts express TLRs, often more abundantly than fibroblasts from controls. This figure depicts the mRNA expression profiles of TLRs 1-9 (normalized to the 18S rRNA control gene) in a panel of three case and two control paired strains, denoted "vest." for vestibular fibroblasts and "vulv." for external vulvar fibroblasts. We found that all strains tested expressed all nine TLRs, while expression was generally higher in cases versus controls. Expression was significantly higher in the vestibular fibroblasts taken from cases (vs controls) for TLRs 1, 2, 4, 7, 8, and 9, denoted by a single asterisk (ANOVA, p < .05, n ≥ 8). Expression of TLR-1 was also significantly higher in external vulvar fibroblasts (vs control). Although there were no significant differences by anatomic location, expression of TLRs 1, 3, 5, 6, 7, and 9 appeared to be slightly elevated in vestibular versus external vulvar fibroblasts.
Toll-Like Receptor 7 Knockdown
Interluekin 6 levels were compared between untreated (normal) cells and those in which TLR-7 expression was inhibited with a small-interfering RNA (siRNA). A siRNA against human TLR-7 was transfected into fibroblasts using Lipofectamine 2000 (ThermoFisher). Cells were then treated with imiquimod, and IL-6 levels were determined.
Statistical Analysis
GraphPad Prism 4 (GraphPad Software Inc, La Jolla, CA) was used to conduct the statistical analysis. Analysis of variance (ANOVA) with a Tukey posttest was used to determine statistical significance, set at p ≤ .05. The data are presented as the mean (SE).
RESULTS
Toll-Like Receptors Are Expressed in Human Vestibular and External Vulvar Fibroblasts
We examined the mRNA expression profiles of TLRs 1-9 in three paired case and two paired control strains (vestibular vs external vulvar fibroblasts). All nine TLR mRNAs were expressed in all case and control fibroblast strains, irrespective of anatomic location of sampling, but the relative mRNA abundance of TLR 1-9 was consistently higher in cases than in controls (see Figure 1) . Toll-like receptors 1, 2, 4, 7, 8, and 9 were significantly more highly expressed in cases than controls ( p ≤ .05), whereas TLR-3 and TLR-6 levels were elevated in cases, but these latter differences did not achieve statistical significance ( p ≤ .1). There were no significant differences in TLR expression in the vestibule versus external vulva. However, in many instances, patient vestibular fibroblasts expressed slightly elevated levels of TLRs, specifically TLRs 1, 2, 3, 7, and 9. These findings suggest that TLR expression is upregulated in cases at sites of pain and may be an important contributor to etiopathogenesis of vulvodynia.
Localized Provoked Vulvodynia Fibroblasts Respond to TLR-Specific Stimuli
We tested the ability of vulvar fibroblasts to respond to a spectrum of TLR-specific stimuli in pain-associated vestibular and pain-free external vulvar fibroblasts obtained from an LPV case. Interleukin-6 production was used as a readout of the FIGURE 2. Localized provoked vulvodynia patient fibroblasts produce IL-6 in response to TLR-specific stimuli. This figure shows the amount of IL-6 produced after exposure to a panel of TLR-specific ligands (from InvivoGen TLR agonist kit). The name of each TLR receptor stimulated is listed on the x-axis. The response was examined in fibroblast strains isolated from painful (vestibular) and nonpainful areas (external vulvar) in a prototypical LPV patient. Overall, vestibular and external vulvar fibroblasts mounted the strongest response to high molecular weight Poly(I:C), while the amount of IL-6 produced was consistently higher from vestibular fibroblasts for all stimuli tested. Data are graphed as the mean(SD), n = 4 replicates. FIGURE 3. Vestibular and external vulvar tissues express TLR-3, 7, and 9 mRNA, and expression is induced by stimulation with their cognate ligands. A, The expression profiles of TLR-3, 7, and 9 mRNAs (normalized to 18S rRNA control gene) in the vestibular (vest.) and external vulvar (vulv.) tissues of three cases, each denoted by a unique symbol. All three TLRs were expressed in all tissue samples, but there were no significant differences in expression by anatomic sampling site. B, The fold induction in mRNA expression(SEM) (over vehicle) for TLR-3, 7, and 9 when treated with their cognate ligands, Poly(I:C), imiquimod, and ODN2006, respectively. We found that treatment with each ligand significantly induced TLR expression, while TLR-7 expression was significantly more highly induced in vestibular versus external vulvar (ext. vulvar) fibroblasts, denoted by a single asterisk (ANOVA, p < .05, n ≥ 8).
TLR-specific proinflammatory response, because IL-6 is made when TLR signaling is turned on. [9] [10] [11] We found that both fibroblast strains responded to all nine TLR stimuli, but vestibular fibroblasts consistently produced higher amounts of IL-6 than external vulvar fibroblasts (see Figure 2) . Heightened IL-6 production in vestibular fibroblasts likely reflects an inherent sensitivity of the vulvar vestibule to a wide spectrum of proinflammatory stimuli, which has been demonstrated for other activators (e.g., zymosan, a yeast cell wall extract) and reflects LPV case pain profiles. [4] [5] [6] [7] High molecular weight Poly(I:C), a viral nucleic acid mimetic, emerged as the most potent inducer of IL-6 production for both vestibular and external vulvar fibroblasts. Toll-like receptor 3 is one of several TLRs involved in recognizing foreign nucleic acids, including TLR-7 and TLR-9. 8, 15 Toll-like receptors 3 and 9 were also more highly expressed in cases at sites of pain (see Figure 1) . Therefore, we elected to further study these three TLRs and their potential contribution to proinflammatory signaling in LPV.
Endosomal, Nucleic Acid Responsive TLRs Are Expressed in Human Vulvar Tissue and Expression Is Upregulated by Their Cognate Ligand
Toll-like receptors 3, 7, and 9 were expressed in vulvar tissue, albeit in similar levels by anatomic site (see Figure 3A) . We went on to examine whether exposure to their cognate ligands would alter TLR 3, 7, or 9 mRNA expression. We found that mRNA expression of all three receptors was upregulated when each was exposed to the appropriate ligand (Poly(I:C) for TLR-3, imiquimod for TLR-7, and ODN2006 for TLR-9) (see Figure 3B) . Furthermore, TLR-7 expression was more highly induced in vestibular versus vulvar fibroblasts ( p ≤ .05), indicating that expression of TLR-7 is highest in areas of pain.
Vulvar Fibroblasts Express TLR-7 Protein
Toll-like receptor 7 is of particular clinical interest because TLR-7 is well recognized to interact with imiquimod, a common therapeutic used clinically to treat genital warts caused by the human papillomavirus (HPV). 22, 23 Vulvar treatment with imiquimod may play a role in eliciting a painful, localized, inflammatory response, particularly with treatment focused on vestibular tissue, potentially promoting a vulvodynia condition. Toll-like receptor 7 protein expression, examined via Western blotting, was elevated in cases versus controls, with the highest levels of expression occurring in the most painful areas (vestibular fibroblasts taken from cases) (see Figure 4) . This finding agrees with the elevated mRNA expression of TLR-7 in vestibular fibroblasts shown in Figures 1 and 3 .
Toll-Like Receptor 7 Is Involved in the Response to Sexually Transmitted Pathogens (HIV)
To further study the possible functional roles of TLR-7 in LPV fibroblasts, we examined fibroblast responses to incubation with live HIV, which is also recognized by TLR-7. 24 We first examined whether HIV could infect and replicate within human vulvar fibroblasts. We found no evidence that HIV can invade or replicate within human vulvar fibroblasts (data not shown). However, recent evidence suggests that other cell types not directly infected by HIV (e.g., fibroblasts) can sense and respond to the presence of virus, often enhancing the ability of the virus to infect target cells. 25 Therefore, we examined the influence of viral exposure on TLR-7 expression; we found that HIV exposure increased TLR-7 mRNA levels in both vestibular and external vulvar fibroblasts after 3 and 7 days of incubation (see Figure 5A ). To determine whether viral exposure induced a proinflammatory response, we monitored IL-6 output and found that levels increased with HIV exposure, especially in vulvodynia-associated vestibular fibroblasts (see Figure 5B) . Overall, TLR-7 seems to play an important role in the response to pathogenic threats to the vulva. Western blot, showing that there were modest differences in protein levels between cases and controls, with the highest level of TLR-7 expression in the vestibular fibroblasts derived from cases.
FIGURE 5. Toll-like receptor 7 is involved in the response to relevant pathogens, such as HIV. A, TLR-7 expression (normalized to 18S rRNA control gene) at 3 and 7 days after exposure to HIV. We found that although HIV did not replicate within vulvar fibroblasts, it did induce elevated expression of TLR-7 (over vehicle), which was highest after 7 days of exposure. B, IL-6 production in culture supernatants at 3 and 7 days after exposure. We found that exposure to HIV did induce IL-6 production, consistent with activation of TLR-7. We found that expression was highest after 7 days and most pronounced in the supernatants collected from vestibular fibroblasts, consistent with elevated pain responses in vestibular fibroblasts and tissues.
TLR-7 Signaling Contributes to IL-6 Production
To evaluate whether TLR-7 signaling is directly involved in the production of IL-6, we knocked down TLR-7 mRNA expression using siRNA in fibroblasts from three different LPV cases. Although siRNA knockdown of TLR-7 did not ablate IL-6 production, there was a significant decrease in the amount of IL-6 produced by both vestibular and external vulvar fibroblasts (see Figure 6 , representative case). Consistent with the relative sensitivity of fibroblast strains to proinflammatory stimuli, pain-associated vestibular fibroblasts produced greater amounts of IL-6 than their external vulvar counterparts.
DISCUSSION
Although vulvodynia is influenced by one or more underlying etiologies whose origins are incompletely understood, 1 recent evidence strongly suggests that dysregulated proinflammatory signaling plays a critical role in pain generation. [4] [5] [6] [26] [27] [28] Commonly prescribed medical treatments may manage the symptoms of pain and psychological distress but are of unproven efficacy and do not address the underlying causes of disease, which remain unknown. 1, 3, 29, 30 Therefore, a better understanding of the inflammatory mechanisms that contribute vulvodynia should translate to the development of effective treatments that will target the true causes of disease.
Using IL-6 as a marker of proinflammatory pain, we found that human vulvar fibroblasts express all nine human TLRs tested, which are involved in the innate immune response to a wide spectrum of microbiological and environmental PAMPs. Interestingly, the strongest IL-6 response occurred with the TLR-3 ligand, Poly (I:C). This was at first surprising, because Poly(I:C) is a viral nucleic acid mimetic. To date, the only microbial stimulus consistently correlated with LPVonset has been vulvovaginal yeast infection 31 caused by Candida albicans, 8, 32 a common vulvovaginal yeast pathogen. [33] [34] [35] In addition to patterns expressed directly on the fungi themselves, nucleic acids released by C. albicans during infection can additionally interact with TLR-3 to elicit a proinflammatory response. 32 At the same time, the presence of numerous active TLRs in LPV fibroblasts suggests that these cells are poised to recognize a wide array of proinflammatory stimuli found in the everyday environment, including bacteria and viruses. Most patients (>70%) report the occurrence of chronic or recurrent yeast infections before LPV onset. 31 However, because most yeast infections are self-diagnosed and treated with over-the-counter medications, 36 it is plausible that a significant number of these cases could represent other PAMP-associated inflammatory responses.
Toll-like receptor 7 was of particular interest because of the TLR-7-imiquimod connection. Our results suggest that imiquimod, although designed to stimulate an inflammatory response that helps clear viral HPV-associated lesions, 22, 23 may be accompanied by an increased LPV risk, because it could stimulate or exacerbate an overactive/painful inflammatory response, characterized by the elevated IL-6 levels. Not only is TLR-7 directly involved in the production of IL-6 in response to imiquimod and infectious agents, but also it tends to be more highly expressed in cases at sites of pain, suggesting that it plays an important role in LPV. It is unclear at this time whether HPV, per se, may have an influence on TLR-7 or other PRRs, particularly with respect to vulvodynia risk.
We propose that increased abundance/activity of numerous PRRs renders vestibular fibroblasts inherently sensitive to proinflammatory stimuli of a wide spectrum of fungal, viral, bacterial, and other environmental PAMPs. Targeting a single TLR does not completely ablate proinflammatory mediator production, for example, knocking down TLR-7 mRNA with siRNA reduced but did not abrogate IL-6 production. Based on this observation, we suspect that the coordinate activity of many PRRs, including the 9 TLRs examined here, leads to elevated proinflammatory mediator production based on redundancy of a proinflammatory, vestibular-focused, innate immune response. Therefore, targeting one, or even a few of these receptors, is unlikely to restore LPV patient proinflammatory mediator levels to a healthy baseline. These findings are in agreement with our previous studies implicating additional receptors (Dectin-1 and BDKRB1/2) in vulvovaginal proinflammatory responses and vulvar pain. 4, 7 Therefore, additional research is necessary to fully elucidate these pathways and design therapeutics that would target these pathways as a whole, without compromising the vulva's requisite ability to respond to infectious threats and other inflammatory insults. FIGURE 6 . Toll-like receptor 7 signaling contributes to IL-6 production by LPV fibroblasts and NFkB signaling is required for response to imiquimod. This figure depicts the impact of TLR-7 inhibition on IL-6 production in imiquimod-stimulated fibroblasts from a prototypical LPV case; one of three cases tested is displayed. The mean(SEM) is displayed. Knockdown of TLR-7 significantly reduced IL-6 production in pain-associated vestibular cells versus cells with normal levels of TLR-7 treated with a control siRNA that does not affect gene expression. This difference is denoted by a single asterisk (ANOVA, p < .05, n = 4). Toll-like receptor 7 expression was also higher in vestibular versus external vulvar fibroblasts, denoted by two asterisks (ANOVA, p < .05, n = 4).
